These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 21923596)

  • 21. Human immunodeficiency virus, pregnancy, and Stevens-Johnson syndrome.
    Shilad A; Predanic M; Perni SC; Houlihan C; Principe D
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1254-6. PubMed ID: 15863600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous adverse reactions to lenalidomide.
    Imbesi S; Allegra A; Calapai G; Musolino C; Gangemi S
    Allergol Immunopathol (Madr); 2015; 43(1):88-91. PubMed ID: 24998775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors.
    Severino G; Chillotti C; De Lisa R; Del Zompo M; Ardau R
    Ann Pharmacother; 2005 Jan; 39(1):162-4. PubMed ID: 15546944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dermatologic emergencies.
    Usatine RP; Sandy N
    Am Fam Physician; 2010 Oct; 82(7):773-80. PubMed ID: 20879700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.
    Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH
    Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe carbamazepine-induced cutaneous reaction in the treatment of post-herpetic neuralgia. Case report.
    Garcia JB; Ferro LS; Carvalho AB; da Rocha RM; de Souza LM
    Rev Bras Anestesiol; 2010; 60(4):429-37. PubMed ID: 20659616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide.
    Thornburg A; Abonour R; Smith P; Knox K; Twigg HL
    Chest; 2007 May; 131(5):1572-4. PubMed ID: 17494808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.
    Dimopoulos M; Spencer A; Attal M; Prince HM; Harousseau JL; Dmoszynska A; San Miguel J; Hellmann A; Facon T; Foà R; Corso A; Masliak Z; Olesnyckyj M; Yu Z; Patin J; Zeldis JB; Knight RD;
    N Engl J Med; 2007 Nov; 357(21):2123-32. PubMed ID: 18032762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug-induced Stevens-Johnson syndrome in a patient with AIDS].
    Schlienger RG; Haefeli WE; Bircher A; Leib SL; Lüscher TF
    Schweiz Rundsch Med Prax; 1993 Aug; 82(33):888-92. PubMed ID: 8372290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lenalidomide in multiple myeloma.
    Thomas SK; Richards TA; Weber DM
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):717-35. PubMed ID: 18070715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stevens-Johnson syndrome associated with furosemide: a case report.
    Wright AA; Vesta KS; Stark JE; Smith WJ
    J Pharm Pract; 2010 Aug; 23(4):367-70. PubMed ID: 21507837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible pulmonary toxicity due to lenalidomide.
    Coates S; Barker A; Spurgeon S
    J Oncol Pharm Pract; 2012 Jun; 18(2):284-6. PubMed ID: 21742815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?
    Mateos MV; García-Sanz R; Colado E; Olazábal J; San-Miguel J
    Br J Haematol; 2008 Feb; 140(3):324-6. PubMed ID: 18067473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network.
    Palumbo A; Falco P; Corradini P; Falcone A; Di Raimondo F; Giuliani N; Crippa C; Ciccone G; Omedè P; Ambrosini MT; Gay F; Bringhen S; Musto P; Foà R; Knight R; Zeldis JB; Boccadoro M; Petrucci MT;
    J Clin Oncol; 2007 Oct; 25(28):4459-65. PubMed ID: 17785703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stevens-Johnson syndrome induced by combination of imatinib and allopurinol.
    Hsieh HJ; Chan AL; Lin SJ
    Chemotherapy; 2009; 55(4):197-9. PubMed ID: 19439939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide-associated thrombocytopenia.
    Duyvendak M; Naunton M; Kingma BJ; Brouwers JR
    Ann Pharmacother; 2005 Nov; 39(11):1936-9. PubMed ID: 16219892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment.
    Dimopoulos MA; Christoulas D; Roussou M; Kastritis E; Migkou M; Gavriatopoulou M; Matsouka C; Mparmparoussi D; Psimenou E; Grapsa I; Efstathiou E; Terpos E
    Eur J Haematol; 2010 Jul; 85(1):1-5. PubMed ID: 20192988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamotrigine-induced Stevens-Johnson syndrome.
    Hilas O; Charneski L
    Am J Health Syst Pharm; 2007 Feb; 64(3):273-5. PubMed ID: 17244876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment.
    Klein U; Neben K; Hielscher T; Heiss C; Ho AD; Goldschmidt H
    Ann Hematol; 2011 Apr; 90(4):429-39. PubMed ID: 20857112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.